Related Experiment Video
Updated: Apr 18, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency
Lemuel Non1, Daniel Brito1, Catherine Anastasopoulou2
1Department of Medicine, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA.
Abstract:
Central diabetes insipidus (CDI) is an infrequent complication of neurosarcoidosis (NS). Its presentation may be masked by adrenal insufficiency (AI) and uncovered by subsequent steroid replacement. A 45-year-old woman with a history of NS presented 2 weeks after abrupt cessation of prednisone with nausea, vomiting, decreased oral intake and confusion. She was diagnosed with secondary AI and intravenous hydrocortisone was promptly begun. Over the next few days, however, the patient developed severe thirst and polyuria exceeding 6 L of urine per day, accompanied by hypernatraemia and hypo-osmolar urine. She was presumed to have CDI due to NS, and intranasal desmopressin was administered. This eventually normalised her urine output and serum sodium. The patient was discharged improved on intranasal desmopressin and oral prednisone. AI may mask the manifestation of CDI because low serum cortisol impairs renal-free water clearance. Steroid replacement reverses this process and unmasks an underlying CDI.
More Related Videos
Related Concept Videos
Diabetes Insipidus II: Pathophysiology
Diabetes Insipidus I: Introduction
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Type I Diabetes III: Clinical Manifestations
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...

